Nivolumab vs Ranitidine

## Nivolumab vs Ranitidine: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Ranitidine**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Ranitidine**: Competitive H2 receptor antagonist.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Ranitidine — 2-3 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Ranitidine — C13H22N4O3S.

**Molecular Weight**: Nivolumab — N/A; Ranitidine — 314.4050 g/mol.

**Type**: Nivolumab — Antibody; Ranitidine — Small molecule.